LoginRegister
    Boehringer Ingelheim to restructure executive boardBoehringer Ingelheim to restructure executive board
    JnJ directed to pay USD 572 million for opioid addiction crisisJnJ directed to pay USD 572 million for opioid addiction crisis
    Amgen to pay hefty $13.4 billion for buying Celgene psoriasis drug OtezlaAmgen to pay hefty $13.4 billion for buying Celgene psoriasis drug Otezla
    CDSCO preparing list of dual-use APIs imported from unregistered firmsCDSCO preparing list of dual-use APIs imported from unregistered firms
    Alkem Labs gets 4 USFDA observations for St Louis facilityAlkem Labs gets 4 USFDA observations for St Louis facility
    Lupin, Glenmark recall hypertension, fungal infection drugs from US marketLupin, Glenmark recall hypertension, fungal infection drugs from US market
    Ghaziabad formulations facility gets 1 USFDA observation: Unichem LaboratoriesGhaziabad formulations facility gets 1 USFDA observation: Unichem Laboratories
    GSK Belantamab Mafodotin shows to help blood cancer patientsGSK Belantamab Mafodotin shows to help blood cancer patients
    Opioid Lawsuit: Oklahoma judge to deliver judgment in first state caseOpioid Lawsuit: Oklahoma judge to deliver judgment in first state case
    CDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone tablet, DetailsCDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone...
    HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 croreHDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore
    USFDA recalls Edwards Lifesciences heart valves delivery system linked to 1 death, 17 injuriesUSFDA recalls Edwards Lifesciences heart valves delivery system linked to 1 death, 17 injuries
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X